NSE
Biocon LimitedBIOCON
Biocon is a biopharmaceuticals company strong in biosimilars.
| Key products | Biosimilars (via Biocon Biologics), generics, APIs and research services (Syngene). |
|---|---|
| Geography | Global. |
| Competitors | Dr Reddy's, global biosimilar makers. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Re 0.50 Per Share
ex 2026-07-03
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | BIOCONThis | — | — | — | — | — | — |
| 2 | CIPLA | — | — | — | — | +19 | 44 |
| 3 | DRREDDY | — | — | — | — | +20 | 46 |
| 4 | SUNPHARMA | — | — | — | — | +15 | 45 |
| 5 | TORNTPHARM | — | — | — | — | — | — |
| 6 | LUPIN | — | — | — | — | — | — |
| 7 | ZYDUSLIFE | — | — | 1 | +1 | — | — |
| 8 | APOLLOHOSP | — | — | 1 | — | — | — |
| 9 | AUROPHARMA | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • [object Object]
- • [object Object]
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-07-03ActionDividend - Re 0.50 Per ShareDividend
- 2026-06-15Filing Kiran Mazumdar-Shaw has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SecuritiShareholding Disclosure
- 2026-06-10FilingBiocon Limited has informed the Exchange about AcquisitionM&A
- 2026-06-08FilingBiocon Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company haMeeting
- 2026-06-08FilingBiocon Limited has informed the Exchange about Schedule of meetInvestor Call
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Source PDF → - 2
- 2
- 2
No bulk/block deals for BIOCON in this window.
Results & transcripts
News & chatter on BIOCON
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.